Featured Insight
Access90: Inflation Reduction Act Insights Series – Patient Affordability: A Key Question Answered
Will the Inflation Reduction Act actually increase drug affordability? Well…it’s complicated. RyanCox, VP, Director, PRECISIONvalue Access Experience Team, outlines the ways it will cut costs—and some watchouts. Learn more in this 90-second video.
Access90: Inflation Reduction Act Insights Series – Impacts on Competition A Key Question Answered
How do you compete against a negotiated drug? As the Inflation Reduction Act challenges current formulary dynamics, PRECISIONvalue expert Erin Lopata has a succinct answer: Prove your value. Learn more in this 90-second video.
Access90: Inflation Reduction Act Insight Series – Payer Controls: Question Two: How Could Manufacturers Adapt Their Approach to Patient Access?
Higher premiums. Increased brand exclusions. Limited treatment populations. Payers may deploy an arsenal of defenses against rising drug costs—and manufacturers should adapt to support patient access. Dominic Galante, Chief Medical Officer PRECISIONvalue, shares thoughts on effective strategies in this short Access90 video.
Access90: Inflation Reduction Act Insights Series – Patient Affordability: A Key Question Answered
Will the Inflation Reduction Act actually increase drug affordability? Well…it’s complicated. RyanCox, VP, Director, PRECISIONvalue Access Experience Team, outlines the ways it will cut costs—and some watchouts. Learn more in this 90-second video.
Access90: Inflation Reduction Act Insights Series – Impacts on Competition A Key Question Answered
How do you compete against a negotiated drug? As the Inflation Reduction Act challenges current formulary dynamics, PRECISIONvalue expert Erin Lopata has a succinct answer: Prove your value. Learn more in this 90-second video.
Access90: Inflation Reduction Act Insight Series – Payer Controls: Question Two: How Could Manufacturers Adapt Their Approach to Patient Access?
Higher premiums. Increased brand exclusions. Limited treatment populations. Payers may deploy an arsenal of defenses against rising drug costs—and manufacturers should adapt to support patient access. Dominic Galante, Chief Medical Officer PRECISIONvalue, shares thoughts on effective strategies in this short Access90 video.
On-Demand Webinar – SDOH and EHR – How are EHR vendors enabling providers’ efforts to close care gaps attributable to SDOH?
In this 1 hour live webinar, Precision experts Thad Nowakowski, Tim Van Aken, and Maureen Hennessey discuss the role that Social Determinants of Health plays in contributing to care gaps, current or proposed quality measures to support health equity, and how the top EHR vendors are enabling end user’s efforts to both capture SDOH variables, and act upon them to close care gaps.
On-Demand Webinar – Trends in Oncology: US Payer Management Considerations for 2022 and Beyond
In the last five years, 83 novel oncology substances have launched - oncology PMPM spend is now the highest among medical benefit categories, with 105% growth anticipated by 2024. As these numbers suggest, oncology is a key area of focus for payers, who are willing to invest resources to support appropriate utilization, but who struggle to keep up with the rapidly evolving science.
On-Demand Webinar – A Novel Data and Analytics-Informed Approach to Launch Excellence
Launching a therapy has become increasingly challenging, with only 34% of launches meeting their year-one goals (Evaluate Pharma, McKinsey). In addition, launches have also become more complex, with additional stakeholders to consider as well as the careful navigation of siloed, enterprise-wide functions and dynamic, fragmented data solutions. Not surprisingly, the path to a successful launch can be very narrow.
A Focus on the Inflation Reduction Act
Curious how the healthcare provisions in the Inflation Reduction Act will impact your business? Start with this booklet by key experts from PRECISIONvalue where 5 experts weigh in on how the Inflation Reduction Act will affect payers in addition to 2023 trends, events, and developments in the payer world. Download the booklet.
White Paper: Achieving Launch Excellence: A Novel Data- and Analytics-Informed Approach
Data and analytics can help drive and inform launch preparations and support efforts to achieve launch excellence through realistic goal-setting and risk mitigation. PRECISIONadvisors works with manufacturers, helping them make key decisions—related to product positioning, go-to-market strategy, and customer engagement across payers, providers, prescribers, and patients—through data- and analytics-driven insights. Learn how an integrated data-driven approach can set realistic goals and de-risk your launch.
White Paper: 2022 and Beyond: How Key Legislative Events Will Impact the Payer Landscape
Interested in learning more about several legislative events shaping the managed care landscape in 2022 and beyond? Check out this insightful white paper, based on our recent webinar, which features insights from PRECISIONvalue’s expert Access Experience Team on various legislative proposals and payers’ potential responses to regulatory changes.
Download Now: Precision October Events Calendar
The October Events Calendar is here! Get all the details on Precision at upcoming conferences, links to upcoming and on-demand webinars, and catch up on our latest thought leadership!
Download Now: Precision September Events Calendar
The October Events Calendar is here! Get all the details on Precision at upcoming conferences, links to upcoming and on-demand webinars, and catch up on our latest thought leadership!
Download Now: Precision June Events Calendar
The June Events Calendar is here! Stay up to date with all of the upcoming Precision conferences, on-demand events and recent thought leadership!
Article: What’s Behind the Slow Uptake of Biosimilars in the US?
Payers have long maintained that the high cost of biologics relative to small-molecule drugs is unsustainable and a threat to their business model. However, a new analysis shows that many plans aren’t yet sold on giving less expensive biosimilars better footing on formularies compared to reference products.
PRECISIONvalue Named a Finalist for the 2023 MM+M awards in the Branded Website for Healthcare Professionals Category
We are excited to announce that PRECISIONvalue has been named a finalist for the 2023 MM+M awards in the Branded Website for Healthcare Professionals category.
PRECISIONvalue Named a Finalist for the 2023 MM+M awards in the Market Access Agency of the Year category
We are thrilled to announce that PRECISIONvalue has been named a Market Access Agency of the Year finalist for the 2023 MM+M awards!
Beyond the PHE: Forging a More Resilient Future
As we transition to a different phase of the COVID-19 pandemic, the need for multistakeholder collaboration continues in order to build resilience and prevent or mitigate future pandemics. Precision's Cynthia Miller identifies steps life science companies can take now with other stakeholder partners.
Shortages All Around: The Implications of Staff Shortages and Rural Hospital Closures on Access to Care
Two important trends that may lead to decreased access to healthcare in the future and worsening disparities. Precision's Cynthia Miller discusses how we got here and a pathway forward.
PRECISIONvalue Named a Finalist in the Medical Conference or Event Marketing Category of the Fierce Pharma Marketing Awards
We are excited to announce that PRECISIONvalue has been named a finalist in the Medical Conference or Event Marketing category of the Fierce Pharma Marketing Awards.
PRECISIONvalue Named a Finalist for the 2023 MM+M awards in the Market Access Agency of the Year category
We are thrilled to announce that PRECISIONvalue has been named a Market Access Agency of the Year finalist for the 2023 MM+M awards!
Beyond the PHE: Forging a More Resilient Future
As we transition to a different phase of the COVID-19 pandemic, the need for multistakeholder collaboration continues in order to build resilience and prevent or mitigate future pandemics. Precision's Cynthia Miller identifies steps life science companies can take now with other stakeholder partners.
Shortages All Around: The Implications of Staff Shortages and Rural Hospital Closures on Access to Care
Two important trends that may lead to decreased access to healthcare in the future and worsening disparities. Precision's Cynthia Miller discusses how we got here and a pathway forward.
PRECISIONvalue Named a Finalist in the Medical Conference or Event Marketing Category of the Fierce Pharma Marketing Awards
We are excited to announce that PRECISIONvalue has been named a finalist in the Medical Conference or Event Marketing category of the Fierce Pharma Marketing Awards.
PRECISIONvalue Named a Finalist in the Innovation Challenge Category of the Fierce Pharma Marketing Awards
We are excited to announce that PRECISIONvalue has been named a finalist in the Innovation Challenge category of the Fierce Pharma Marketing Awards.
Post-PHE Medicaid Disenrollment and Employer Group Enrollment Impact
With the end of the COVID-19 Public Health Emergency and national emergency on May 11, 2023, Medicaid state agencies have begun the process of redetermining which Medicaid participants may no longer be eligible and, consequently, dropped from Medicaid. Precision's Jorge Font addresses the potential impact to commercial/employer plan enrollment shifts resulting from the unwinding of Medicaid continuous coverage protection.
On-demand Webinar: Gene Therapies In Hemophilia
As the first ‘big wave’ in the gene therapy space, onetime potentially curative treatments for hemophilia present a potential revolution for many thousands of patients. Watch this on-demand webinar and Q&A moderated by Precision's Larry Blandford, as we explore these challenges, and discuss solutions to getting innovative therapies into the hands of patients who need them most.
On-demand Webinar: Using HEOR Methods to Reduce Health Inequalities
Current social and political events have brought renewed attention to the levels of systemic inequalities faced by millions of minorities in the United States and around the world. Moderated by Precision's Kelly Wilder, join us and learn how innovative health economics and outcomes research (HEOR) methods can be leveraged to quantify the full value new treatments that improve health outcomes for underserved communities.
On-Demand Webinar: Healthcare Trends in 2021 — How New Clinical and Scientific Innovations Are Shifting the Paradigm
In the first part of our Trends webinar series, our experts discussed how this shift has facilitated novel collaboration between health systems, plans, and pharmaceutical manufacturers and has also led to many new opportunities--but how is the healthcare landscape responding? Join us to learn how new clinical and scientific innovations are shifting the healthcare paradigm.
On-Demand Webinar: Beyond the First 100 Days: Healthcare Policy and Value-Based Care Trends That You Need to Know
Join Precision experts Ross Maclean, Dominic Galante and Maureen Hennessey as they offer insights into trends that are gaining velocity. Watch "Beyond the First 100 Days: Healthcare Policy and Value-Based Care Trends That You Need to Know" on-demand today.
On-demand Webinar: 2020 Social Determinants of Health Series–Assessing and Addressing Social Determinants of Health During a Pandemic
Join us for a webinar featuring KOLs emphasizing applied learnings in the SDOH and population health fields.
HLTH Conference Video: The Science & Politics of Developing a COVID-19 Vaccine & Treatment
Congratulations to Precision Medicine Group Co-Founder and CEO Mark Clein on his moderated Point: Counterpoint panel at this year’s HLTH Conference.
AJMC Center for Biosimilars: How to Encourage Biosimilar Uptake, Cultural Changes and Formulary Placement
A deep dive into the future of biosimilars: In this In this exclusive 2-part video interview for AJMC's Center for Biosimilars, editor Matthew Gavidia speaks with PRECISIONvalue's Ryan Cox to discuss what employers can do to encourage biosimilar uptake, the cultural changes that are needed to make it happen, and whether midsize employers can participate in payer discussions on formulary placement.
On-demand Webinar: Wish I Knew Then What I Know Now–How Cell and Gene Therapies are Reshaping Commercialization Strategies
In this webinar, Carolyn Morgan of PRECISIONeffect moderates an expert panel exploring the challenges of commercializing a cell or gene therapy from industry trailblazers.